1. Neuropilin‐2 and its ligand VEGF‐C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients. Issue 2 (12th June 2014) Authors: Keck, B.; Wach, S.; Taubert, H.; Zeiler, S.; Ott, O.J.; Kunath, F.; Hartmann, A.; Bertz, S.; Weiss, C.; Hönscheid, P.; Schellenburg, S.; Rödel, C.; Baretton, G.B.; Sauer, R.; Fietkau, R.; Wullich, B.; Krause, F.S.; Datta, K.; Muders, M.H. Journal: International journal of cancer Issue: Volume 136:Issue 2(2015:Jan. 15) Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Role of neuropilin-2 in the immune system. (October 2017) Authors: Schellenburg, S.; Schulz, A.; Poitz, D.M.; Muders, M.H. Journal: Molecular immunology Issue: Volume 90(2017:Oct.) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗